160 related articles for article (PubMed ID: 17106249)
21. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
23. Mesoporous silicon particles for sustained gene silencing.
Hasan N; Mann A; Ferrari M; Tanaka T
Methods Mol Biol; 2013; 1049():481-93. PubMed ID: 23913239
[TBL] [Abstract][Full Text] [Related]
24. Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.
Meryet-Figuière M; Lecerf C; Varin E; Coll JL; Louis MH; Dutoit S; Giffard F; Blanc-Fournier C; Hedir S; Vigneron N; Brotin E; Pelletier L; Josserand V; Denoyelle C; Poulain L
Oncol Rep; 2017 Oct; 38(4):1949-1958. PubMed ID: 28791387
[TBL] [Abstract][Full Text] [Related]
25. siRNA delivery for the treatment of ovarian cancer.
Goldberg MS
Methods; 2013 Sep; 63(2):95-100. PubMed ID: 23403216
[TBL] [Abstract][Full Text] [Related]
26. Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.
Zhang Y; Sriraman SK; Kenny HA; Luther E; Torchilin V; Lengyel E
Mol Cancer Ther; 2016 Oct; 15(10):2282-2293. PubMed ID: 27466355
[TBL] [Abstract][Full Text] [Related]
27. Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
Inoue M; Matsumoto S; Saito H; Tsujitani S; Ikeguchi M
Int J Cancer; 2008 Dec; 123(11):2696-701. PubMed ID: 18798274
[TBL] [Abstract][Full Text] [Related]
28. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
[TBL] [Abstract][Full Text] [Related]
29. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
30. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
[TBL] [Abstract][Full Text] [Related]
31. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
32. Use of avidin/biotin-liposome system for enhanced peritoneal drug delivery in an ovarian cancer model.
Zavaleta CL; Phillips WT; Soundararajan A; Goins BA
Int J Pharm; 2007 Jun; 337(1-2):316-28. PubMed ID: 17276633
[TBL] [Abstract][Full Text] [Related]
33. Targeted Therapy for Breast Cancer Stem Cells by Liposomal Delivery of siRNA against Fibronectin EDB.
Sun Y; Kim HS; Saw PE; Jon S; Moon WK
Adv Healthc Mater; 2015 Aug; 4(11):1675-80. PubMed ID: 26097122
[TBL] [Abstract][Full Text] [Related]
34. Liposomal delivery of gene therapy for ovarian cancer: a systematic review.
Son JS; Chow R; Kim H; Lieu T; Xiao M; Kim S; Matuszewska K; Pereira M; Nguyen DL; Petrik J
Reprod Biol Endocrinol; 2023 Aug; 21(1):75. PubMed ID: 37612696
[TBL] [Abstract][Full Text] [Related]
35. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.
Mikhaylova M; Stasinopoulos I; Kato Y; Artemov D; Bhujwalla ZM
Cancer Gene Ther; 2009 Mar; 16(3):217-26. PubMed ID: 18927599
[TBL] [Abstract][Full Text] [Related]
36. Efficient inhibition of intraperitoneal ovarian cancer growth in nude mice by liposomal delivery of short hairpin RNA against STAT3.
Jiang Q; Dai L; Cheng L; Chen X; Li Y; Zhang S; Su X; Zhao X; Wei Y; Deng H
J Obstet Gynaecol Res; 2013 Mar; 39(3):701-9. PubMed ID: 23003327
[TBL] [Abstract][Full Text] [Related]
37. Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy.
Chen Y; Wang X; Liu T; Zhang DS; Wang Y; Gu H; Di W
Int J Nanomedicine; 2015; 10():2579-94. PubMed ID: 25848273
[TBL] [Abstract][Full Text] [Related]
38. Chitosan hydrogel for localized gene silencing.
Han HD; Mora EM; Roh JW; Nishimura M; Lee SJ; Stone RL; Bar-Eli M; Lopez-Berestein G; Sood AK
Cancer Biol Ther; 2011 May; 11(9):839-45. PubMed ID: 21358280
[TBL] [Abstract][Full Text] [Related]
39. [Effect of S1PR2 inhibition on epithelial ovarian cancer SKOV3 cell proliferation in vitro and in vivo].
Dai L; Liu YX; Xie L; Di W
Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):106-110. PubMed ID: 29534379
[No Abstract] [Full Text] [Related]
40. Enhancement of ovarian cancer chemotherapy by delivery of multidrug-resistance gene small interfering RNA using tumor targeting Salmonella.
Deng J; Guo Y; Jiang Z; Yang M; Li H; Wang J
J Obstet Gynaecol Res; 2015 Apr; 41(4):615-22. PubMed ID: 25370788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
